Pharmacokinetics, pharmacodynamics and safety of CEP-26401, a high-affinity histamine-3 receptor antagonist, following single and multiple dosing in healthy subjects

Author(s):
Spiegelstein, O.; Stevens, J.; Gerven, J. van; Nathan, P.J.; Maynard, J.P.; Mayleben, D.W.; Hellriegel, E.; Yang, R.H.
Published
2016
Publication type
Article / Letter to editor
Pharmacokinetics and drug metabolismpharmacodynamics (PDY)population pharmacokineticscentral nervous system (CNS)clinical trials (CTR)histamine-3 receptor antagonist
Date issued
2016-10-31
Language
English
Is part of
Journal of Psychopharmacology (2016), Vol. 30, no. 10, p. 983-993
hdl
1887/112008
doi
10.1177/0269881116645301